Eden Medical Genomics

Company Overview

Snapshot

Founded in August 2024 by Elisha David, Eden Medical Genomics operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on R&D for its proprietary Genome Language Model (GLM). However, the company ceased operations in December 2025.

Business overview

Eden Medical Genomics is a Health Tech & Life Sciences company developing a proprietary Genome Language Model (GLM) to revolutionize medical genomics. The company's core technology leverages Artificial Intelligence to serve various markets within Healthcare & Life Sciences, including Biotechnology, Pharmaceuticals, Insurance Companies, Providers, and Laboratories. It operates within sectors such as Digital Healthcare, Digital Medical Diagnostics, Digital Therapeutics, Medical Decision Support, and Clinical Workflow.

Company Intelligence Q&A

What is the primary focus of Eden Medical Genomics?

Eden Medical Genomics focuses on revolutionizing medical genomics through its proprietary Genome Language Model (GLM), utilizing Artificial Intelligence as its core technology.

When was Eden Medical Genomics founded and by whom?

Eden Medical Genomics was founded in August 2024 by Elisha David, who serves as the Founder & CEO.

What is the current operational status of Eden Medical Genomics?

Eden Medical Genomics ceased to operate in December 2025 and is currently in a non-active status.

Which industries does Eden Medical Genomics target?

Eden Medical Genomics targets the Healthcare & Life Sciences industries, specifically focusing on Biotechnology, Pharmaceuticals, Insurance Companies, Providers, and Laboratories.